Cardiovascular Measures in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Who Are New Users of Methylphenidate and Atomoxetine-Reference-Cited by-同舟云学术

Cardiovascular Measures in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Who Are New Users of Methylphenidate and Atomoxetine

Published:2012-12 Issue:6 Volume:22 Page:423-431
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Arcieri Romano¹,Germinario Elena A.P.¹,Bonati Maurizio²,Masi Gabriele³,Zuddas Alessandro⁴,Vella Stefano¹,Chiarotti Flavia⁵,Panei, and the Italian Attention-De Pietro¹

Affiliation:

1. Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy.

2. Maternal and Child Health Laboratory, Institute Mario Negri, Milan, Italy.

3. IRCCS Stella Maris, Scientific Institute of Child Neurology and Psychiatry, Calambrone, Pisa, Italy.

4. Department of Neuroscience, Section of Child Neuropsychiatry, University of Cagliari, Cagliari, Italy.

5. Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2012.0014

Reference23 articles.

1. Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

2. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias∗∗This document does not cover atrial fibrillation; atrial fibrillation is covered in the ACC/AHA/ESC guidelines on the management of patients with atrial fibrillation found on the ACC, AHA, and ESC Web sites.—executive summary

3. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis

4. Normal ECG standards for infants and children

5. Cardiovascular Effects of Medications for the Treatment of Attention-Deficit Hyperactivity Disorder

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis;Neuroscience & Biobehavioral Reviews;2023-01

2. Cardiovascular Considerations for Stimulant Class Medications;Child and Adolescent Psychiatric Clinics of North America;2022-07

3. Methylphenidate-Associated Syncope;Journal of Clinical Psychopharmacology;2022-06-11

4. The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review;Frontiers in Psychiatry;2022-02-09

5. Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice;Pediatric Drugs;2022-02-09